Posted by Michael Wonder on 13 Mar 2018
Cancer panel calls for measures to lower drug costs
13 March 2018 - In a report, the President’s Cancer Panel says drugs aren’t delivering enough benefits for their costs; stops short of outlining concrete steps.
A panel that advises the White House on cancer policy said urgent action is needed to curb a dramatic rise in the price of cancer drugs, which can cost more than $100,000 a year and mean thousands of dollars in out-of-pocket payments for many patients.
“More than ever, affordable access to drugs will be the difference between life and death for cancer patients,” wrote members of the President’s Cancer Panel. “Many new drugs do not provide benefits commensurate with their prices.”
